Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/14750

Acronycine: Target Organs and Levels of Evidence for TR-049

Bioassay of Acronycine for Possible Carcinogenicity (CASRN 7008-42-6)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Acronycine
7008-42-6
03/07/1978Intraperitoneal Injection
R: 0,3.75,7.5,15, M: 0,2,6,12.5,25 MG/KG/35 PER GROUP
Southern Research Institute

Levels of Evidence

Male Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Bone: (OSTEOSARCOMA)
  • Mesothelium (Abdominal Cavity/Tunica Vaginalis): MESOTHELIOMA; SARCOMA
Female Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Mammary Gland: (ADENOCARCINOMA)
  • Mesothelium (Abdominal Cavity/Tunica Vaginalis): MESOTHELIOMA; SARCOMA
Male Mice: Inadequate Study
Female Mice: Inadequate Study